Demand Planning in Pharma: Expiry Risks, Supply Gaps Explained

Demand planning in pharma has never been simple. It operates at a critical convergence where science rigor meets regulation, supply chain complexity, and commercial pressure. When it works well, it protects both patients and revenue. When it falters, the consequences show up quietly at first, in expiring inventory, regional imbalances, and missed supply signals and then suddenly, in shortages.

The uncomfortable truth is this: most pharma companies do not have a demand planning problem. They have a visibility problem.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

The Gap Between Forecasts and Reality

Traditional demand planning processes are built around structured cycles, monthly forecast reviews, quarterly S&OP meetings, inventory reconciliation exercises.

Those processes are necessary. But they are not sufficient anymore.

Today’s pharma supply chains are exposed to:

In that environment, a demand forecasting is only as useful as the speed at which it can trigger action.

Yet in many organizations, the signals sit quietly inside systems:

The data exists. What’s missing is the connective tissue between it.

Silent Expiries: A Symptom of Reactive Demand Planning

Expiry write-offs rarely happen overnight.

They build slowly, often visible in ERP systems months in advance. But without continuous monitoring and cross-functional alignment, those early signals don’t convert into decisions.

Demand planning teams may see the forecast. Supply chain teams may see the inventory. Regulatory may be assessing changes in parallel.

But unless those views are connected, expiry risk becomes a lagging indicator rather than a leading one.

By the time someone manually reconciles the data across systems, the decision window has narrowed or closed.

Why Demand Planning Must Become Proactive

Demand planning in pharma can no longer be limited to forecast accuracy metrics.

It must answer harder, more operational questions:

These are not reporting questions. They are decision questions.

And they require more than spreadsheets and static dashboards.

They require continuous monitoring across inventory, batch data, demand outlook, and supply constraints with insights delivered to the right people before risk materializes.

From Planning Cycles to Continuous Demand Intelligence

The shift in demand planning is subtle but significant.

It moves from: From: From:

When demand planning is supported by connected intelligence, expiry risk is flagged early. Supply gaps get caught early. Decisions get made faster. Not because the process changed — but because the context was there when it mattered.

This is not about replacing planning teams. It is about equipping them with better visibility.

Where Intelligent Workflow Support Makes a Difference

One of the practical applications of this approach is 90-day expiry monitoring — a common blind spot in pharma demand planning.

Instead of waiting for manual reconciliation, systems can continuously evaluate:

And surface simple, actionable insights:

When those insights are embedded directly into daily supply chain workflows, demand planning shifts from reactive correction to proactive risk management.

Demand Planning as a Strategic Lever

In a regulated industry, demand planning is not just about operational efficiency.

It protects:

The organizations that navigate volatility successfully are not necessarily those with the most sophisticated forecasting models. They are the ones that connect planning, inventory, supply, and regulatory insight into a single, coherent view.

The question is not whether your systems hold the data. They do.

The question is whether your demand planning process can see risk early enough to act.

Rethinking Demand Planning in Pharma

As volatility becomes the norm, demand planning must evolve from a forecasting function to a continuous intelligent demand forecasting function.

If your current demand planning process still depends heavily on manual reconciliation and periodic reviews, the next expiry write-off or shortage may already be visible, just not connected.

Originally published at https://saxon.ai on March 5, 2026.